Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Share News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.40
Bid: 1.30
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.20 (15.385%)
Open: 1.40
High: 1.40
Low: 1.40
Prev. Close: 1.40
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECT: Getech signs deal; AfriTin confirms name change

Wed, 11th Jan 2023 09:30

(Corrects that Zenith Energy is based in Canada, not in Scotland.)

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Getech Group PLC - Leeds, England-based geo-energy and green hydrogen company - Signs a strategic collaboration agreement with Eavor Technology Inc. Says the companies will work together to locate and derisk multiple closed-loop geothermal projects for development across Latin America. "This exciting agreement with Eavor is an important first step in building Getech's global geothermal asset portfolio. By integrating our geoscience data and geospatial/economic modelling skills with Eavor's development technology, it will be possible to establish geothermal development assets of significant scale," Chief Executive Jonathan Copus comments.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Completes the pre-clinical rodent trial for its CimetrA anti-inflammatory treatment. Explains that the pre-clinical results are needed for US FDA investigational drug approval. Says that no pathological or cytotoxic changes at all were found in the organs and tissue biopsies of the test subjects. "The successful completion of this study and the excellent results attained is an important milestone moment for the company, as we continue to progress CimetrATM along the mandated clinical pathway. The results of this study are a critical step in advancing MGC's submission to the FDA, and for the final approval of CimetrATM as an investigational new drug in the US," Co-founder & CEO Roby Zomer comments.

----------

Kefi Gold & Copper PLC - Cyprus-based gold and copper exploration and development company with projects in Ethiopia and Saudi Arabia - Upgrades the mineral resource estimate at the Hawiah project to 29.0 million tonnes from 2.1 million tonnes. Receives five additional exploration licenses through the company's Gold & Minerals Ltd joint venture in Saudi Arabia. These are the Wadi Na'afa, Al Awja, Abu Salal North, Umm Al Khabath and Jabal Selm licenses, which were awarded on an initial 5-year term. Says that the drilling in Hawiah will begin in the second quarter of 2023 and is aimed at increasing the MRE. "With our rapidly advancing gold projects in Ethiopia and Saudi Arabia, where we are heading for steady-state production from 2025, we are delighted to have been awarded these five further exploration licences in Saudi Arabia to further broaden the KEFI GMCO portfolio," Executive Chair Harry Anagnostaras-Adams comments.

----------

AfriTin Mining Ltd - technology metals mining company focused on Namibia - Confirms that it is changing its name to Andrada Mining Ltd. The name change will be effective from January 11, 0800 GMT. "I'm delighted to confirm the company's change of name and we look forward to rebranding as Andrada Mining. The company's potential lithium resource size in Namibia is extremely exciting, and the change of name reflects the importance of it within our growing production profile, beyond our existing tin operation. We look to the future with huge excitement as Andrada Mining plays its part in the energy transition," CEO Anthony Viljoen comments.

----------

Zenith Energy Ltd - Calgary, Canada-based energy company with production, exploration and development assets in Tunisia, Italy, and the Republic of Congo - Says it was awarded an exclusivity for Block 1 containing the Seme oilfield, offshore Benin from the Ministry of Water & Mines of the Republic of Benin. "Block-1 represents a potentially transformational development opportunity for Zenith because of its sizeable unexploited potential, indicated by its independently assessed oil and gas reserves and past production, and existing field infrastructure. We view Benin as an attractive jurisdiction for foreign investment and we look forward with great enthusiasm to working closely with the local authorities towards successfully formalising the PSC," Chief Executive Andrea Cattaneo comments.

----------

Kropz PLC - African phosphate developer - Estimates that its total phosphate resources at Elandsfontein in South Africa stands at 106.6 million tonnes. Reports a proven reserve of 7.31 million tonnes at 10.7% phosphorus pentoxide. Downgrades a lot of its previously measured resources to "indicated" and previously "indicated" resources to "inferred." Notes that total measured and indicated resource tonnages have reduced by around 76%. "While the downgrade of the Measured and Indicated resource is disappointing, it enables Kropz to move forward with a significantly increased level of confidence, that will allow for accurate and efficient mine planning. The increase in total resource, and more importantly, the increase in grade, supported by the additional drilling programme is excellent news, and the continued drilling planned for the year ahead will further increase confidence, and support an increase in reserve tonnes," CEO Mark Summers comments.

----------

Dekel Agri-Vision PLC - palm oil and cashew grower in West Africa - Reports that its crude palm oil output for 2022 is down 36%. For December it reports a fall of 20%, year-on-year. Notes that 2022 is a record year for palm oil pricing. Says that the average crude palm oil price in 2022 stood at EUR1,025, up 18% versus EUR868 year-on-year. Expects to still be one of the best-performing years since its inception. "With the annual high season commencing shortly we are hopeful of improved fresh fruit bunches harvesting volumes. Together with continued robust prices we are well positioned to see a strengthening in financial profitability. We will continue to report the palm oil operation data monthly to ensure our shareholders are well informed during this exciting period for the company," Executive Director Lincoln Moore says.

----------

Thor Explorations Ltd - Vancouver-based mineral explorer with assets in west Africa - Reports that its gold production for the Segilola gold mine is at the top end of the guidance range of 90,000 to 100,000 ounces for 2022, with production of 98,006oz. Completes a reverse circulation drilling campaign of 26,000 metre at Douta. Makes a new discovery with the Sambara prospect. Guides for 85,000 to 95,000 oz of gold weighted towards the second half of the year for 2023 as a whole. "Continuing high grade drill results from our Douta project in Senegal underline the potential that we see in this asset, and we are working to move this project forward to development. Now that Segilola is at steady state operation, the company is also focusing on our growth strategy in Nigeria where we have an aggressive drill program on a number of targets and continue to evaluate potential opportunities, to leverage our technical capabilities and first mover advantage," President & CEO Segun Lawson comments.

----------

Central Asia Metals PLC - copper, zinc and lead explorer operating in Kazakhstan and North Macedonia - Reports record copper production at Kounrad that is above its guidance range with 4,254 tonnes of copper produced. Says that its zinc and lead production at Sasa were within the guidance range with zinc in concentrate production of 21,473 tonnes and lead in concentrate production of 27,354 tonnes. Guides for Kounrad copper production of between 13,000 and 14,000 tonnes of cathode in 2023. "We enter 2023 in a debt-free position and look forward to delivering another year of strong base metal production and beginning the transition to the cut and fill mining method at Sasa," CEO Nigel Robinson comments.

----------

IQ-AI Ltd - Jersey-based medical services firm - Reports "significant progress" in the phase I clinical trial of gallium maltolate. In addition, it is increasing its focus on accelerating the deployment of IB Clinic. IB Clinc is a toolkit of post-processing software plug-ins designed to be integrated into existing medical image visualization applications.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Limited. All Rights Reserved.

More News
18 Aug 2023 12:17

IQ-AI shares jump on subsidiary's GE Healthcare deal

(Alliance News) - IQ-AI Ltd on Friday said its wholly-owned subsidiary Imaging Biometrics LLC has signed a deal with GE HealthCare Technologies Inc.

Read more
17 Aug 2023 11:21

IQ-AI interim loss narrows amid higher revenue, lower expenses

(Alliance News) - IQ-AI Ltd on Thursday announced a slightly lower loss for the six months to June 30, as revenue was up and administrative expenses were lower.

Read more
19 Jul 2023 10:45

IN BRIEF: IQ-AI subsidiary's app adopted by US medical college

IQ-AI Ltd - Jersey-based medical services firm focused on cancer treatment - Says subsidiary Imaging Biometrics LLC's handheld application IB Nimble has been adopted by the Medical College of Wisconsin's Orthopedic Department for use in bone metastases treatment. IB Nimble's designer, Joseph Bovi, is professor of radiation oncology & neurosurgery at MCW. The application was originally designed to help treat brain metastases. IQ-AI says it "provides real-time collaboration amongst multi-disciplinary teams" to "provide optimised treatments faster". Josh McComack, Imaging Biometrics' director of software engineering, says the new installation "demonstrates that IB Nimble is ready for widespread deployment."

Read more
13 Jul 2023 11:36

IN BRIEF: IQ-AI granted orphan drug designation for Gallium Galtolate

IQ-AI Ltd on Thursday - Jersey-based incubator of software and other tools for the treatment of cancer - IQ-AI subsidiary Imaging Biometrics LLC has been granted an orphan drug designation for Gallium Galtolate for the treatment of paediatric glioblastoma multiforme, or GBM, by the US Food & Drug Administration. Says GBM is the most common and aggressive primary brain tumour in adults and children. Imaging Biometrics' application to the FDA was first submitted in April. In June, two pre-clinical studies showed oral GaM inhibits brain tumour growth in children, and the results were consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin.

Read more
27 Jun 2023 11:47

IN BRIEF: IQ-AI notes Gallium Moltate studies on tumour growth

IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC's two new pre-clinical studies show oral Gallium Maltolate inhibits brain tumour growth in children. Says the results are consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin. This follows IB's application for Orphan Drug Designation to the US Food & Drug Administration back in April for the use of GaM in pediatric brain tumours. Notes application is currently under review.

Read more
23 May 2023 16:12

TRADING UPDATES: Harworth optimistic on 2027; Plexus extends agreement

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
16 May 2023 15:53

UK shareholder meetings calendar - next 7 days

Wednesday 17 May 
Alpha Group International PLCAGM
Aptitude Software Group PLCAGM
Aston Martin Lagonda Global Holdings PLCAGM
Baillie Gifford Shin Nippon PLCAGM
Cenkos Securities PLCGM re all-share merger between Cenkos and finnCap
Coats Group PLCAGM
Coca-Cola HBC AGAGM
Computacenter PLCAGM
Conduit Holdings LtdAGM
EKF Diagnostics Holdings PLCAGM
finnCap Group PLCGM re all-share merger between Cenkos and finnCap
Gamma Communications PLCAGM
Georgia Capital PLCAGM
Greggs PLCAGM
HgCapital Trust PLCAGM
Highcroft Investments PLCAGM
Impact Healthcare REIT PLCAGM
Just Eat Takeaway.com NVAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Mpac Group PLCAGM
Savills PLCAGM
Tortilla Mexican Grill PLCAGM
TP ICAP Group PLCAGM
WPP PLCAGM
Thursday 18 May 
Ascential PLCAGM
Asimilar Group PLCAGM
Belvoir Group PLCAGM
Bridgepoint Group PLCAGM
Capital LtdAGM
Central Asia Metals PLCAGM
Ceres Power Holdings PLCAGM
ConvaTec Group PLCAGM
Diaceutics PLCAGM
Digital 9 Infrastructure PLCAGM
Energean PLCAGM
European Assets Trust PLCAGM
Fintel PLCAGM
Genuit Group PLCAGM
Inchcape PLCAGM
Invesco Asia Trust PLCAGM
JPMorgan American Investment Trust PLCAGM
Legal & General Group PLCAGM
Lloyds Banking Group PLCAGM
Merchants Trust PLCAGM
Michelmersh Brick Holdings PLCAGM
musicMagpie PLCAGM
Next PLCAGM
Network International Holdings PLCAGM
NIOX Group PLCAGM
PensionBee Group PLCAGM
Public Policy Holding Co IncAGM
Quilter PLCAGM
Riverstone Energy LtdAGM
Safestyle UK PLCAGM
Science Group PLCAGM
Secure Trust Bank PLCAGM
Smart Metering Systems PLCAGM
Somero Enterprises IncAGM
St James's Place PLCAGM
Tyman PLCAGM
Unite Group PLCAGM
Vesuvius PLCAGM
Vistry Group PLCAGM
Yu Group PLCAGM
Friday 19 May 
Bank of Georgia Group PLCAGM
Permanent TSB Group Holdings PLCAGM
Sancus Lending Group LtdAGM
Monday 22 May 
Blackrock Latin American Investment Trust PLCAGM
Crossword Cybersecurity PLCAGM
Judges Scientific PLCAGM
Stelrad Group PLCAGM
Venture Life Group PLCAGM
Tuesday 23 May 
888 Holdings PLCAGM
Access Intelligence PLCAGM
Arix Bioscience PLCAGM
Bank of Ireland Group PLCAGM
Big Technologies PLCAGM
Bigblu Broadband PLCAGM
Centamin PLCAGM
CT Private Equity Trust PLCAGM
Empresaria Group PLCAGM
Epwin Group PLCAGM
Forterra PLCAGM
Fresnillo PLCAGM
Fulcrum Utility Services LtdGM re issue of conversion shares
Gresham Technologies PLCAGM
Harworth Group PLCAGM
Hilton Food Group PLCAGM
hVIVO PLCAGM
HydrogenOne Capital Growth PLCAGM
IQ-AI LtdAGM
JTC PLCAGM
K3 Business Technology Group PLCAGM
Pebble Group PLCAGM
Portmeirion Group PLCAGM
PPHE Hotel Group LtdAGM
Restaurant Group PLCAGM
Shell PLCAGM
Sherborne Investors (Guernsey) C LtdAGM
TMT Investments PLCAGM
Triple Point Income VCT PLCAGM
Triple Point Social Housing REIT PLCAGM
Trustpilot Group PLCAGM
Twentyfour Income Fund LtdAGM
Wickes Group PLCAGM
Xeros Technology Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
26 Apr 2023 14:43

EARNINGS SUMMARY: Third Point Investors NAV per share drops by quarter

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
28 Feb 2023 19:40

TRADING UPDATES: AIQ revenue soars; Mobius Investment net assets drop

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
10 Jan 2023 21:34

TRADING UPDATES: Getech signs deal; AfriTin confirms name change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
16 Aug 2022 14:39

IN BRIEF: IQ-AI shares plummet on widening interim loss

IQ-AI Ltd - Jersey-based medical services firm - Posts larger interim pretax loss due to increased administrative costs. Pretax loss in the half-year to June 30 widens to GBP330,584 from GBP207,135 a year ago. Revenue climbs 7.2% to GBP255,609 from GBP238,488. However, revenue growth is offset by administrative costs increasing by 34% to GBP583,346 from GBP436,247.

Read more
11 Jul 2022 13:34

IN BRIEF: IQ-AI launches IB Clinic on Bayer Calantic platform

IQ-AI Ltd - Jersey-based medical services firm - Says its medical imaging analysis software, IB Clinic, is now available via the newly launched Bayer Calantic platform. The distribution partnership continues its strategy of making IB Clinic accessible to healthcare providers through widespread networks, the company adds.

Read more
31 May 2022 13:26

IN BRIEF: IQ-AI shares rise with submission of application to US FDA

IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC submits 510(k) application to US Food & Drug Administration for IB Zero G, an artificial intelligence software that eliminates the need for gadolinium-based contrast agents in routine magnetic imagining exams. "The FDA 510(k) submission is the first step in potentially transforming the global gadolinium-based contrast agent market and introducing a paradigm shift in radiology departments," company says.

Read more
31 May 2022 10:44

SMALL-CAP WINNERS & LOSERS: IQ-AI's IB Zero G moves closer to approval

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.